149 related articles for article (PubMed ID: 34096828)
1. Venlafaxine and O-desmethylvenlafaxine serum levels are positively associated with antidepressant response in elder depressed out-patients.
De Donatis D; Porcelli S; Zernig G; Mercolini L; Giupponi G; Serretti A; Conca A; Florio V
World J Biol Psychiatry; 2022 Mar; 23(3):183-190. PubMed ID: 34096828
[TBL] [Abstract][Full Text] [Related]
2. Prediction of antidepressant response to venlafaxine by a combination of early response assessment and therapeutic drug monitoring.
Stamm TJ; Becker D; Sondergeld LM; Wiethoff K; Hiemke C; O'Malley G; Ricken R; Bauer M; Adli M
Pharmacopsychiatry; 2014 Jul; 47(4-5):174-9. PubMed ID: 25054625
[TBL] [Abstract][Full Text] [Related]
3. Venlafaxine's therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis.
Lense XM; Hiemke C; Funk CSM; Havemann-Reinecke U; Hefner G; Menke A; Mössner R; Riemer TG; Scherf-Clavel M; Schoretsanitis G; Gründer G; Hart XM
Psychopharmacology (Berl); 2024 Feb; 241(2):275-289. PubMed ID: 37857898
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant polypharmacy and the potential of pharmacokinetic interactions: Doxepin but not mirtazapine causes clinically relevant changes in venlafaxine metabolism.
Paulzen M; Haen E; Hiemke C; Fay B; Unholzer S; Gründer G; Schoretsanitis G
J Affect Disord; 2018 Feb; 227():506-511. PubMed ID: 29156365
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting.
Reis M; Lundmark J; Björk H; Bengtsson F
Ther Drug Monit; 2002 Aug; 24(4):545-53. PubMed ID: 12142641
[TBL] [Abstract][Full Text] [Related]
6. Effect of venlafaxine dosage, valproic acid concentration, sex, and age on steady state dose-corrected concentrations of venlafaxine and O-desmethylvenlafaxine: A retrospective analysis of therapeutic drug monitoring data in a Chinese population.
Wang ZZ; Deng SH; Lu HY; Li L; Zhu XQ; Hu JQ; Xie HS; Chen HZ; Chen YQ; Zhang M; Fang ZY; Wen YG; Shang DW
Hum Psychopharmacol; 2020 May; 35(3):e2733. PubMed ID: 32239743
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine plasma level and antidepressant response.
De Donatis D; Florio V; Porcelli S; Saria A; Mercolini L; Serretti A; Conca A
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():127-132. PubMed ID: 30611837
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele.
Hermann M; Hendset M; Fosaas K; Hjerpset M; Refsum H
Eur J Clin Pharmacol; 2008 May; 64(5):483-7. PubMed ID: 18214456
[TBL] [Abstract][Full Text] [Related]
9. Serum and Saliva Concentrations of Venlafaxine, O-Desmethylvenlafaxine, Quetiapine, and Citalopram in Psychiatric Patients.
Ebert K; Maurice E; Lukačin R; Fleischhaker C; Schulz E; Ebert D; Clement HW
Ther Drug Monit; 2018 Jun; 40(3):351-355. PubMed ID: 29746434
[TBL] [Abstract][Full Text] [Related]
10. Steady-state serum concentrations of venlafaxine in patients with late-life depression. Impact of age, sex and BMI.
Sigurdsson HP; Hefner G; Ben-Omar N; Köstlbacher A; Wenzel-Seifert K; Hiemke C; Haen E
J Neural Transm (Vienna); 2015 May; 122(5):721-9. PubMed ID: 25257248
[TBL] [Abstract][Full Text] [Related]
11. Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: analysis of therapeutic drug monitoring data under naturalistic conditions.
Unterecker S; Reif A; Hempel S; Proft F; Riederer P; Deckert J; Pfuhlmann B
Int Clin Psychopharmacol; 2014 Jul; 29(4):206-11. PubMed ID: 24374906
[TBL] [Abstract][Full Text] [Related]
12. Selective solid-phase extraction using molecularly imprinted polymers for analysis of venlafaxine, O-desmethylvenlafaxine, and N-desmethylvenlafaxine in plasma samples by liquid chromatography-tandem mass spectrometry.
Miranda LF; Domingues DS; Queiroz ME
J Chromatogr A; 2016 Aug; 1458():46-53. PubMed ID: 27388659
[TBL] [Abstract][Full Text] [Related]
13. Time course of clinical response to venlafaxine: relevance of plasma level and chirality.
Gex-Fabry M; Balant-Gorgia AE; Balant LP; Rudaz S; Veuthey JL; Bertschy G
Eur J Clin Pharmacol; 2004 Feb; 59(12):883-91. PubMed ID: 14704834
[TBL] [Abstract][Full Text] [Related]
14. The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions.
Unterecker S; Hiemke C; Greiner C; Haen E; Jabs B; Deckert J; Pfuhlmann B
Pharmacopsychiatry; 2012 Sep; 45(6):229-35. PubMed ID: 22426847
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects.
Ciusani E; Zullino DF; Eap CB; Brawand-Amey M; Brocard M; Baumann P
J Psychopharmacol; 2004 Dec; 18(4):559-66. PubMed ID: 15582923
[TBL] [Abstract][Full Text] [Related]
16. CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression.
Men X; Taylor ZL; Marshe VS; Blumberger DM; Karp JF; Kennedy JL; Lenze EJ; Reynolds CF; Stefan C; Mulsant BH; Ramsey LB; Müller DJ
Clin Pharmacol Ther; 2024 May; 115(5):1065-1074. PubMed ID: 38284409
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic drug monitoring of antidepressants: Why venlafaxine is the most monitored drug? A review of literature].
Couderc S; Mory C; Darnaud L; Saint-Marcoux F
Therapie; 2021; 76(6):725-733. PubMed ID: 33551091
[TBL] [Abstract][Full Text] [Related]
18. The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes.
Jiang F; Kim HD; Na HS; Lee SY; Seo DW; Choi JY; Ha JH; Shin HJ; Kim YH; Chung MW
Psychopharmacology (Berl); 2015 Jun; 232(11):1899-909. PubMed ID: 25510856
[TBL] [Abstract][Full Text] [Related]
19. Rapid determination of venlafaxine and O-desmethylvenlafaxine in human plasma by high-performance liquid chromatography with fluorimetric detection.
Vu RL; Helmeste D; Albers L; Reist C
J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):195-201. PubMed ID: 9448076
[TBL] [Abstract][Full Text] [Related]
20. Reduced clearance of venlafaxine in a combined treatment with quetiapine.
Paulzen M; Schoretsanitis G; Hiemke C; Gründer G; Haen E; Augustin M
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():116-121. PubMed ID: 29702137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
